Torrent Pharmaceuticals Limited (TORNTPHARM) — Announcement | 11 August 2026(2 announcements)

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Announcement Neutral 📄 PDF
📢 Key Event
Company schedules investor meetings under SEBI Regulation 30
💡 Investor Takeaway
Shareholders should note the company is actively engaging institutional investors, which may influence short-term trading activity and liquidity.

Torrent Pharmaceuticals announced its participation in an investors' meet hosted by Emkay on August 14, 2026, in Mumbai, as part of Regulation 30 compliance for SEBI disclosure obligations. The filing confirms scheduled one-on-one and group meetings with institutional investors, subject to change based on company or investor exigencies.

2 Announcement Neutral 📄 PDF
📢 Key Event
NSE assigns Torrent Pharmaceuticals an ESG rating of 70
💡 Investor Takeaway
The ESG rating underscores Torrent's sustainability efforts and could attract responsible investment.

Torrent Pharmaceuticals announced that NSE Sustainability Ratings and Analytics assigned the company an ESG rating of 70, reflecting its environmental, social, and governance performance. This rating highlights the firm's commitment to sustainable practices and may enhance its appeal to ESG-focused investors.

About Torrent Pharmaceuticals Limited (TORNTPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,49,108.91 Cr P/E: 80.1

View full TORNTPHARM stock details →

📡 Get AI alerts when TORNTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track TORNTPHARM — Free

📊 More TORNTPHARM filings

See all TORNTPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when TORNTPHARM files new disclosures

Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track TORNTPHARM — Free

Free account · 2 AI queries/day